More than half of all human cancers have mutations that disable a protein called p53. When cells lose p53, tumors grow aggressively and often cannot be treated. But a new study may offer a way to counteract the problem. The scientists have succeeded in shutting off the growth of p53-deficient tumors by turning up the production of TAp63 proteins, a class of proteins produced by the p63 gene.